Bill Snyder Archive — Page 47 of 121

Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
November 2, 2020

VUMC begins study of second COVID-19 vaccine

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.

Portrait of Charles Foster (Chuck) Federspiel, PhD, wearing a dark suit and striped tie.
October 30, 2020

VUMC mourns loss of Biostatistics pioneer Federspiel

Charles Foster (Chuck) Federspiel, PhD, a beloved member of the Vanderbilt University faculty for 61 years and founding director of the Division of Biostatistics, died on Oct. 19. He was 91.

Portrait of a smiling woman with short dark hair wearing a black top, posed in front of a pink-and-white brick wall.
October 30, 2020

Former Vanderbilt Prize winner Amon mourned

Angelika Amon, PhD, a pioneering cell and molecular biologist and winner of the 2018 Vanderbilt Prize in Biomedical Science, died Oct. 29 from cancer. She was 53.

Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
October 26, 2020

COVID treatment studied by VUMC gains FDA approval

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.

Close-up of a high-tech laboratory interface displaying the words “COVID-19” and “VIRUS,” with colorful circuit-like lines and data graphics.
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

Conceptual 3D illustration of red, spiked SARS-CoV-2 particles surrounded by Y-shaped ACE2 receptors on a glowing orange background.
October 15, 2020

Possible COVID-19 “decoy”

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.